New vaccine aims to block HPV cancers not covered by current shots

NCT ID NCT05985681

First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 30 times

Summary

This early-stage trial tests a new vaccine called RG1-VLP in 18 healthy women aged 18–60. The vaccine is designed to protect against HPV types that current vaccines don't cover, which can cause certain cancers. Researchers will check if the vaccine is safe and triggers a strong immune response.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMAVIRUS-RELATED CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Johns Hopkins University/Sidney Kimmel Cancer Center

    WITHDRAWN

    Baltimore, Maryland, 21287, United States

  • Medical University Vienna

    NOT_YET_RECRUITING

    Vienna, A-1090, Austria

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Staten Island University Hospital

    WITHDRAWN

    Staten Island, New York, 10305, United States

  • University of Alabama at Birmingham Cancer Center

    WITHDRAWN

    Birmingham, Alabama, 35233, United States

  • University of Wisconsin Carbone Cancer Center - University Hospital

    RECRUITING

    Madison, Wisconsin, 53792, United States

    Contact Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.